264 related articles for article (PubMed ID: 25470645)
1. Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects.
Mirzaei K; Hossein-nezhad A; Keshavarz SA; Koohdani F; Eshraghian MR; Saboor-Yaraghi AA; Hosseini S; Chamari M; Zareei M; Djalali M
Diabetes Metab Syndr; 2015; 9(4):292-8. PubMed ID: 25470645
[TBL] [Abstract][Full Text] [Related]
2. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance.
Anwar GM; Yamamah G; Ibrahim A; El-Lebedy D; Farid TM; Mahmoud R
Regul Pept; 2014 Jan; 188():21-4. PubMed ID: 24333832
[TBL] [Abstract][Full Text] [Related]
3. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.
Abaci A; Catli G; Anik A; Kume T; Bober E
Pediatr Diabetes; 2013 May; 14(3):189-95. PubMed ID: 23346951
[TBL] [Abstract][Full Text] [Related]
4. Possible resting metabolic rate modification by the circulating RBP4 in obese subjects.
Ansar H; Mirzaei K; Malek A; Najmafshar A; Hossein-nezhad A
Diabetes Metab Syndr; 2015; 9(1):19-23. PubMed ID: 25450816
[TBL] [Abstract][Full Text] [Related]
5. Mediatory effect of circulating vaspin on resting metabolic rate in obese individuals.
Moradi S; Mirzaei K; Abdurahman AA; Keshavarz SA; Hossein-Nezhad A
Eur J Nutr; 2016 Apr; 55(3):1297-305. PubMed ID: 26058881
[TBL] [Abstract][Full Text] [Related]
6. Association between nesfatin-1 levels and metabolic improvements in severely obese patients who underwent biliopancreatic derivation with duodenal switch.
St-Pierre DH; Martin J; Shimizu H; Tagaya Y; Tsuchiya T; Marceau S; Biertho L; Bastien M; Caron-Cantin SM; Simard S; Richard D; Cianflone K; Poirier P
Peptides; 2016 Dec; 86():6-12. PubMed ID: 27681383
[TBL] [Abstract][Full Text] [Related]
7. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity.
Anık A; Çatlı G; Abacı A; Küme T; Bober E
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):623-8. PubMed ID: 24825087
[TBL] [Abstract][Full Text] [Related]
8. Nesfatin-1 hormone levels in morbidly obese patients after laparoscopic sleeve gastrectomy.
Dogan U; Bulbuller N; Cakır T; Habibi M; Mayir B; Koc U; Aslaner A; Ellidag HY; Gomceli I
Eur Rev Med Pharmacol Sci; 2016; 20(6):1023-31. PubMed ID: 27049252
[TBL] [Abstract][Full Text] [Related]
9. Plasma nesfatin-1 level in obese patients after acupuncture: a randomised controlled trial.
Guo Y; Xing M; Sun W; Yuan X; Dai H; Ding H
Acupunct Med; 2014 Aug; 32(4):313-7. PubMed ID: 24813558
[TBL] [Abstract][Full Text] [Related]
10. The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation?
Saldanha JF; Carrero JJ; Lobo JC; Stockler-Pinto MB; Leal VO; Calixto A; Geloneze B; Mafra D
Regul Pept; 2012 Jan; 173(1-3):82-5. PubMed ID: 22036920
[TBL] [Abstract][Full Text] [Related]
11. Obesity, inflammation and resting energy expenditure: possible mechanism of progranulin in this pathway.
Hossein-Nezhad A; Mirzaei K; Ansar H; Emam-Gholipour S; Tootee A; Keshavarz SA
Minerva Endocrinol; 2012 Sep; 37(3):255-66. PubMed ID: 22766892
[TBL] [Abstract][Full Text] [Related]
12. Resting energy expenditure, cardiovascular risk factors and insulin resistance in obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
Ann Nutr Metab; 2005; 49(6):381-5. PubMed ID: 16219989
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of leptin, nesfatin-1 and kisspeptin in postmenopausal obese women.
Çelik F; Belviranli M; Okudan N
Arch Physiol Biochem; 2016 Oct; 122(4):195-199. PubMed ID: 27011110
[TBL] [Abstract][Full Text] [Related]
14. A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease.
Başar O; Akbal E; Köklü S; Koçak E; Tuna Y; Ekiz F; Gültuna S; Yιlmaz FM; Aydoğan T
Scand J Clin Lab Invest; 2012 Oct; 72(6):479-83. PubMed ID: 22950627
[TBL] [Abstract][Full Text] [Related]
15. Variants in the PPARGC1A Gene may Influence the Effect of Fat Intake on Resting Metabolic Rate in Obese Women.
Moradi S; Mirzaei K; Maghbooli Z; Abdurahman AA; Keshavarz SA
Lipids; 2018 Mar; 53(3):291-300. PubMed ID: 29663401
[TBL] [Abstract][Full Text] [Related]
16. Effects of upper-body resistance exercise training on serum nesfatin-1 level, insulin resistance, and body composition in obese paraplegic men.
Mogharnasi M; TaheriChadorneshin H; Papoli-Baravati SA; Teymuri A
Disabil Health J; 2019 Jan; 12(1):29-34. PubMed ID: 30061073
[TBL] [Abstract][Full Text] [Related]
17. NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.
Hofmann T; Stengel A; Ahnis A; Buße P; Elbelt U; Klapp BF
Psychoneuroendocrinology; 2013 Nov; 38(11):2502-10. PubMed ID: 23796625
[TBL] [Abstract][Full Text] [Related]
18. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment.
Tan BK; Hallschmid M; Kern W; Lehnert H; Randeva HS
J Clin Endocrinol Metab; 2011 Apr; 96(4):E669-73. PubMed ID: 21252251
[TBL] [Abstract][Full Text] [Related]
19. Alterations of circulating NUCB2/nesfatin-1 during short term therapeutic improvement of anxiety in obese inpatients.
Hofmann T; Weibert E; Ahnis A; Obbarius A; Elbelt U; Rose M; Klapp BF; Stengel A
Psychoneuroendocrinology; 2017 May; 79():107-115. PubMed ID: 28273586
[TBL] [Abstract][Full Text] [Related]
20. The relation of serum nesfatin-1 level with anthropometric and metabolic parameters in children and adolescents: A prospective observational study.
Kim SH; Ahn MB; Cho WK; Cho KS; Jung MH; Suh BK
Medicine (Baltimore); 2019 May; 98(19):e15460. PubMed ID: 31083178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
